Hundreds of millions of people worldwide are affected by rare diseases. Behind every case is a family enduring a diagnostic odyssey that can last for years. To improve how public health systems help ...
Precision medicine models often rely on data from Northern European populations, leading to treatment inequities. Genetic diversity is crucial for understanding disease risk and treatment efficacy, as ...
The study also demonstrates that genetic architecture plays a critical role in determining model performance. Traits influenced by a smaller number of significant genetic loci are more effectively ...
The team hopes its models can help patients get diagnoses for rare diseases.
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in ...
Osteosarcoma (OS) is the most common type of primary bone malignancy. Common genetic variants including single nucleotide polymorphisms (SNPs) have been associated with osteosarcoma risk, however, the ...
A remote genetics-first workflow used a no-imputation SNP panel GRS (AUC >0.9) with saliva collection and high-throughput ...
Hundreds of genes have been linked to autism, yet the precise molecular and cellular mechanisms behind it remain largely unclear. A new study published in Nature, led by Gaia Novarino at the Institute ...
One key research goal of evolutionary biology is to understand the origin and maintenance of genetic variation. In the Cerrado, the South American savanna located primarily in the Central Brazilian ...
A comprehensive understanding of the genetic architecture of tree growth, a complex interplay of genetics between the plant's above- and below-ground parts, remains undefined in plant studies.
Feixiong Cheng, PhD, and a Cleveland Clinci research team have successfully applied advanced artificial intelligence genetics models to Parkinson's disease. Researchers from the Cleveland Clinic ...
Researchers have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results